vs
Bankwell Financial Group, Inc.（BWFG）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Bankwell Financial Group, Inc.的1.2倍（$35.5M vs $30.3M），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 43.3%），Bankwell Financial Group, Inc.自由现金流更多（$27.1M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 17.2%）
Bankwell金融集团是美国的银行控股企业，提供个人及商业银行全品类产品服务，包含存款账户、住房贷款、商业信贷、财富管理解决方案，主要服务康涅狄格州的本地社区、零售客户及中小微企业。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
BWFG vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.2倍
$30.3M
营收增速更快
RXRX
高出638.5%
43.3%
自由现金流更多
BWFG
多$74.4M
$-47.3M
两年增速更快
RXRX
近两年复合增速
17.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $30.3M | $35.5M |
| 净利润 | — | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 46.9% | -304.8% |
| 净利率 | — | -304.2% |
| 营收同比 | 43.3% | 681.7% |
| 净利润同比 | — | 39.6% |
| 每股收益（稀释后） | $1.16 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BWFGRXRX
| Q4 25 | $30.3M | $35.5M | ||
| Q3 25 | $28.5M | $5.2M | ||
| Q2 25 | $25.9M | $19.2M | ||
| Q1 25 | $23.6M | $14.7M | ||
| Q4 24 | $21.2M | $4.5M | ||
| Q3 24 | $21.9M | $26.1M | ||
| Q2 24 | $21.9M | $14.4M | ||
| Q1 24 | $22.1M | $13.8M |
净利润BWFGRXRX
| Q4 25 | — | $-108.1M | ||
| Q3 25 | $10.1M | $-162.3M | ||
| Q2 25 | $9.1M | $-171.9M | ||
| Q1 25 | $6.9M | $-202.5M | ||
| Q4 24 | — | $-178.9M | ||
| Q3 24 | $1.9M | $-95.8M | ||
| Q2 24 | $1.1M | $-97.5M | ||
| Q1 24 | $3.8M | $-91.4M |
毛利率BWFGRXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率BWFGRXRX
| Q4 25 | 46.9% | -304.8% | ||
| Q3 25 | 47.3% | -3327.6% | ||
| Q2 25 | 45.5% | -916.8% | ||
| Q1 25 | 38.0% | -1297.9% | ||
| Q4 24 | 19.2% | -4042.4% | ||
| Q3 24 | 12.4% | -377.1% | ||
| Q2 24 | 6.7% | -697.4% | ||
| Q1 24 | 23.0% | -698.4% |
净利率BWFGRXRX
| Q4 25 | — | -304.2% | ||
| Q3 25 | 35.4% | -3135.3% | ||
| Q2 25 | 35.0% | -894.2% | ||
| Q1 25 | 29.2% | -1373.3% | ||
| Q4 24 | — | -3935.5% | ||
| Q3 24 | 8.8% | -367.5% | ||
| Q2 24 | 5.1% | -676.6% | ||
| Q1 24 | 17.1% | -662.4% |
每股收益（稀释后）BWFGRXRX
| Q4 25 | $1.16 | $-0.17 | ||
| Q3 25 | $1.27 | $-0.36 | ||
| Q2 25 | $1.15 | $-0.41 | ||
| Q1 25 | $0.87 | $-0.50 | ||
| Q4 24 | $0.37 | $-0.56 | ||
| Q3 24 | $0.24 | $-0.34 | ||
| Q2 24 | $0.14 | $-0.40 | ||
| Q1 24 | $0.48 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $192.1M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $301.5M | $1.1B |
| 总资产 | $3.4B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资BWFGRXRX
| Q4 25 | $192.1M | $743.3M | ||
| Q3 25 | $128.2M | $659.8M | ||
| Q2 25 | $142.6M | $525.1M | ||
| Q1 25 | $136.0M | $500.5M | ||
| Q4 24 | $146.1M | $594.4M | ||
| Q3 24 | $145.9M | $427.6M | ||
| Q2 24 | $138.0M | $474.3M | ||
| Q1 24 | $126.2M | $296.3M |
总债务BWFGRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益BWFGRXRX
| Q4 25 | $301.5M | $1.1B | ||
| Q3 25 | $292.8M | $1.0B | ||
| Q2 25 | $283.3M | $919.1M | ||
| Q1 25 | $275.2M | $933.9M | ||
| Q4 24 | $270.5M | $1.0B | ||
| Q3 24 | $267.9M | $524.6M | ||
| Q2 24 | $267.0M | $584.4M | ||
| Q1 24 | $268.0M | $401.2M |
总资产BWFGRXRX
| Q4 25 | $3.4B | $1.5B | ||
| Q3 25 | $3.2B | $1.4B | ||
| Q2 25 | $3.2B | $1.3B | ||
| Q1 25 | $3.2B | $1.3B | ||
| Q4 24 | $3.3B | $1.4B | ||
| Q3 24 | $3.2B | $726.5M | ||
| Q2 24 | $3.1B | $775.9M | ||
| Q1 24 | $3.2B | $557.8M |
负债/权益比BWFGRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.3M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $27.1M | $-47.3M |
| 自由现金流率自由现金流/营收 | 89.5% | -133.1% |
| 资本支出强度资本支出/营收 | 3.8% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $47.0M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流BWFGRXRX
| Q4 25 | $28.3M | $-46.1M | ||
| Q3 25 | $10.3M | $-117.4M | ||
| Q2 25 | $6.5M | $-76.4M | ||
| Q1 25 | $3.9M | $-132.0M | ||
| Q4 24 | $29.9M | $-115.4M | ||
| Q3 24 | $-557.0K | $-59.2M | ||
| Q2 24 | $7.1M | $-82.2M | ||
| Q1 24 | $9.0M | $-102.3M |
自由现金流BWFGRXRX
| Q4 25 | $27.1M | $-47.3M | ||
| Q3 25 | $9.9M | $-117.6M | ||
| Q2 25 | $6.1M | $-79.6M | ||
| Q1 25 | $3.8M | $-133.8M | ||
| Q4 24 | $29.3M | $-116.7M | ||
| Q3 24 | $-672.0K | $-63.8M | ||
| Q2 24 | $6.8M | $-83.4M | ||
| Q1 24 | $8.9M | $-109.0M |
自由现金流率BWFGRXRX
| Q4 25 | 89.5% | -133.1% | ||
| Q3 25 | 34.9% | -2272.5% | ||
| Q2 25 | 23.5% | -413.9% | ||
| Q1 25 | 16.2% | -907.4% | ||
| Q4 24 | 138.6% | -2567.7% | ||
| Q3 24 | -3.1% | -244.6% | ||
| Q2 24 | 31.0% | -578.5% | ||
| Q1 24 | 40.5% | -789.9% |
资本支出强度BWFGRXRX
| Q4 25 | 3.8% | 3.5% | ||
| Q3 25 | 1.4% | 4.7% | ||
| Q2 25 | 1.5% | 16.4% | ||
| Q1 25 | 0.4% | 12.4% | ||
| Q4 24 | 2.9% | 28.6% | ||
| Q3 24 | 0.5% | 17.5% | ||
| Q2 24 | 1.7% | 8.2% | ||
| Q1 24 | 0.4% | 48.2% |
现金转化率BWFGRXRX
| Q4 25 | — | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 0.71× | — | ||
| Q1 25 | 0.57× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.29× | — | ||
| Q2 24 | 6.39× | — | ||
| Q1 24 | 2.40× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
